Furthermore, higher GCN5 expression within cancer samples was evidently associated with poor overall survival (OS) in KIRC, SARC, ACC, and LAML malignancies, as demonstrated by Kaplan–Meier analysis (Fig. 7h). The gene discussed is KAT2A; the disease is cancer.